Navigation Links
The Female Health Company Executes On Commitment Made At London Summit On Family Planning
Date:2/20/2013

sector; the economic and business environment and the impact of government pressures; risks involved in doing business on an international level, including currency risks, regulatory requirements, political risks, export restrictions and other trade barriers; the Company's production capacity, efficiency and supply constraints; changes in costs of raw materials, labor costs and other manufacturing costs; and other risks detailed in the Company's press releases, shareholder communications and Securities and Exchange Commission filings, including the Company's Form 10‑K for the fiscal year ended September 30, 2012.  Actual events affecting the Company and the impact of such events on the Company's operations may vary from those currently anticipated.

For more information about the Female Health Company visit the Company's website at http://www.femalehealth.com and http://www.femalecondom.org If you would like to be added to the Company's email alert list, please send an e-mail to FHCInvestor@femalehealthcompany.com


'/>"/>
SOURCE The Female Health Company
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
2. The Female Health Company Reports Second Quarter Operating Results
3. Attorneys for Class of Female VPs and SVPs Employed by PR Giant MSLGroup Clarify Companys Inaccurate Description of Federal Courts Recent Certification Ruling
4. Palatin Technologies Announces Last Patient Completed Treatment In Phase 2B Bremelanotide Female Sexual Dysfunction Trial
5. The Female Health Company to Report FY2012 Operating Results on Tuesday, December 4, 2012
6. The Female Health Company Reports Record Fourth Quarter and FY2012 Operating Results
7. The Female Health Company To Report First Quarter Operating Results on Wednesday, January 30, 2013
8. The Female Health Company Reports Record First Quarter FY2013 Operating Results
9. Nutrilys Del Mar Joins Health Forces With LAPD Underwater Dive Unit
10. Clinical Trial at Evergreen Healthcare Shows Intestinal Gel Reduces Symptoms of Advanced Parkinsons Disease
11. Netsmarts Focus on Innovation to Help Health and Human Service Providers Span the Spectrum of Care in the Healthcare 3.0 Environment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... THOUSAND OAKS, Calif. , May 22, ... today announced the Company has commenced termination ... commercialization of brodalumab with AstraZeneca (LON:AZN, STO:AZN ... investigational IL-17 inhibitor, is in development for ... and axial spondyloarthritis.  The decision was based ...
(Date:5/22/2015)... May 22, 2015 The Assistance Fund announces ... program provides financial assistance for copay to individuals diagnosed ... announce the addition of the Melanoma Copay Assistance Program ... McGreevy , executive director. "With each additional program we ... a world where no one is denied access to ...
(Date:5/22/2015)... May 22, 2015  The U.S. Food and ... -- the first biosimilar product approved in ... toward growth in the contract manufacturing organization (CMO) ... industry is geared to the production of small-molecular ... biopharmaceutical products. The healthcare market research publisher,s report, ...
Breaking Medicine Technology:Amgen to terminate participation in co-development and commercialization of brodalumab 2Amgen to terminate participation in co-development and commercialization of brodalumab 3Amgen to terminate participation in co-development and commercialization of brodalumab 4Amgen to terminate participation in co-development and commercialization of brodalumab 5The Assistance Fund Adds Melanoma Assistance Program 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 4
... April 26, 2012 Upsher-Smith Laboratories, Inc. ( ... the pharmacokinetic (PK) profile of USL255, its once-daily, ... 64th Annual American Academy of Neurology (AAN) Meeting.  ... USL255 and equal doses of immediate-release (IR) topiramate ...
... effects of Neupro ® (rotigotine transdermal system) on ... today at the 64th AAN Annual Meeting in New ... data from five, randomized, double-blind,  placebo-controlled trials investigated the ... fatigue in patients with PD. Improvements were observed with ...
Cached Medicine Technology:Upsher-Smith Research Shows Unique Pharmacokinetic Profile of USL255 Extended Release Topiramate 2Upsher-Smith Research Shows Unique Pharmacokinetic Profile of USL255 Extended Release Topiramate 3Upsher-Smith Research Shows Unique Pharmacokinetic Profile of USL255 Extended Release Topiramate 4Upsher-Smith Research Shows Unique Pharmacokinetic Profile of USL255 Extended Release Topiramate 5New post-hoc analyses examined Neupro® effects on pain, depressed mood, apathy and fatigue in patients with Parkinson's disease 2New post-hoc analyses examined Neupro® effects on pain, depressed mood, apathy and fatigue in patients with Parkinson's disease 3New post-hoc analyses examined Neupro® effects on pain, depressed mood, apathy and fatigue in patients with Parkinson's disease 4New post-hoc analyses examined Neupro® effects on pain, depressed mood, apathy and fatigue in patients with Parkinson's disease 5New post-hoc analyses examined Neupro® effects on pain, depressed mood, apathy and fatigue in patients with Parkinson's disease 6New post-hoc analyses examined Neupro® effects on pain, depressed mood, apathy and fatigue in patients with Parkinson's disease 7New post-hoc analyses examined Neupro® effects on pain, depressed mood, apathy and fatigue in patients with Parkinson's disease 8New post-hoc analyses examined Neupro® effects on pain, depressed mood, apathy and fatigue in patients with Parkinson's disease 9New post-hoc analyses examined Neupro® effects on pain, depressed mood, apathy and fatigue in patients with Parkinson's disease 10
(Date:5/24/2015)... May 24, 2015 Women's Excellence ... hair loss. Although it is unclear about the etiology ... environmental factors such as metabolism, nutritional deficiencies, thyroid abnormalities ... offer a comprehensive approach to evaluating the metabolic, nutritional ... they can help patients find a cause for their ...
(Date:5/24/2015)... Scientists with Cardno ChemRisk, a scientific consulting ... issues that may have raised the risk of mesothelioma ... posted an article on the research. Click here ... airborne asbestos levels well above OSHA safety guidelines when ... , “Asbestos compliance sampling data associated with the construction, ...
(Date:5/24/2015)... ProPin is a set of self-animating 3D ... Utilize ProPin to pin point locations on a map, to indicate ... ProPin allows users to choose from 30 simplistic presets with geometric ... controls, video editors can easily manipulate ProPin presets as a whole. ... absolute ease. , Using ProPin is easy, simply drag a preset ...
(Date:5/24/2015)... (PRWEB) May 24, 2015 ... System CEO - The students ... honored at the fourth annual A ... 15 at Geneva National in Lake ... ,     -Badger High School,         Jonathan Alfonso, ...
(Date:5/23/2015)... Washington, D.C. (PRWEB) May 23, 2015 ... demonstration of powers of a youngster's yogic power learned ... by Sri Nithyananda Swami in Bangalore, India. , Yogamaatha, ... of more than 50 high profile professionals attending the ... D.C. by reading fluently -- blindfolded. , In ...
Breaking Medicine News(10 mins):Health News:Women's Excellence Now Treats Menopausal Hair Loss 2Health News:New Analysis Finds Too Many Employers Ignored OSHA Asbestos Guidelines, According to Surviving Mesothelioma 2Health News:Developers at Pixel Film Studios Release ProPin for Final Cut Pro X. 2Health News:Mercy Foundation Honors 16 Students for Making a Difference - Mercy Health System Javon Bea 2Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 2Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 3
... save more in treatment costs under Medicare and ... according to a recent study. , "Chronic conditions ... and employers," said Dennis Scanlon, professor of health ... of the study. "Assessing the financial impact of ...
... method uncovered more players in painful gastrointestinal condition ... international team of researchers has pinpointed new genetic ... chronic and painful condition caused by inflammation of ... Philadelphia-led group used a new gene-searching method, combining ...
... Must Reform Ineffective 33-year-old Chemicals Law, Expert Testifies WASHINGTON, ... nation,s main chemicals law, the Toxic Substances Control Act ... the safety of the tens of thousands of chemicals ... conclusion of expert testimony provided at a hearing ...
... The powerful chemotherapy and radiation used to save cancer ... Research in a new field called oncofertility has advanced ... of women, men and children who are diagnosed with ... strategies to help their patients. , A leading oncofertility ...
... As the voice of the global clinical ... (ACRO) had the honor of presenting before the ... 2009 in Tokyo. ACRO Chair Derek Winstanly, MBChB, ... ACRO Executive Director Douglas Peddicord, Ph.D. addressed "Representing ...
... Pack Your Bag(TM) Program Brings Educational Outreach to ... out of ten older Americans have at least ... pressure or diabetes. With many of these older ... risk for drug interactions when certain medications are ...
Cached Medicine News:Health News:Team-based diabetes care fetches more value for dollar 2Health News:Scientists Discover New Drug Targets for Crohn's Disease 2Health News:Main U.S. Toxics Law Failing to Ensure Safety of Thousands of Chemicals 2Health News:Main U.S. Toxics Law Failing to Ensure Safety of Thousands of Chemicals 3Health News:New tool guides doctors to save cancer patients' fertility 2Health News:New tool guides doctors to save cancer patients' fertility 3Health News:ACRO Presents at Japan CRO Association Commemorative Symposium 2Health News:Video: CVS/pharmacy and National Council on Aging Kick Off Medication Management Program for Seniors 2Health News:Video: CVS/pharmacy and National Council on Aging Kick Off Medication Management Program for Seniors 3
RapidStrep A test is a qualitative test that detects group A,streptococcal antigen. The test is a rapid, in vitro assay. It is,intended for professional use to help diagnose Strep A,infection i...
... caused by the intracellular parasite Toxoplasma gondii ... or by contract with cat,feces containing oocytes. ... be passed to the fetus through the ... is a cause of mortality and malformation.,This ...
... an immunochromatographic in vitro assay,for detection ... infection.,Infectious mononucleosis (IM) is caused by ... is based on detection of,serum antibodies ... the,heterophile antibodies present in the sera ...
Inquire...
Medicine Products: